RayCare is interoperable with Varian TrueBeam
RaySearch Laboratories AB (publ) is proud to announce that the oncology information system RayCare®* can connect to Varian TrueBeam® linear accelerators. This is the result of the interoperability agreement with Varian Medical Systems that was signed in 2020.
The ability to schedule radiation treatments and keep track of the treatment progress is a key functionality in an oncology information system (OIS). To support an integrated workflow, it is necessary for data to flow between the OIS and the treatment delivery system, in this case the Varian TrueBeam linear accelerators (linacs). This kind of bi-lateral connection is referred to as interoperability, and after an extensive program with joint development and testing, Varian has now certified that RayCare is interoperable with the TrueBeam platform. This applies to all linacs in the TrueBeam family: TrueBeam, TrueBeam STx, Edge and VitalBeam.
TrueBeam is Varian’s most prevalent treatment delivery platform and has been installed in thousands of radiation therapy clinics in the world since its launch in 2010. It supports all treatment techniques and capabilities that are provided by so called c-arm linacs, including IMRT, VMAT and electrons with flexible beam energy selection and non-coplanar beam arrangements.
Johan Löf, founder and CEO, RaySearch, says: “As previously communicated, achieving interoperability between RayCare and TrueBeam has taken longer than originally planned. That said, we have learned a lot in the process, and we appreciate the dedication of the Varian engineering teams in this work. We expect that this will drastically increase the addressable market for RayCare, and we look forward to exploring additional potential areas of collaboration and interoperability with Varian products.”
For more information, please contact:
Johan Löf, founder and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0) 8 510 530 00
johan.lof@raysearchlabs.com
Henrik Bergentoft, CFO, RaySearch Laboratories AB (publ)
Telephone: +46 (0) 8 510 530 00
henrik.bergentoft@raysearchlabs.com
About RaySearch
RaySearch Laboratories AB (publ) is a medical technology company that develops innovative software solutions for improved cancer treatment. RaySearch markets the RayStation®* treatment planning system (TPS) and the oncology information system (OIS) RayCare®*. The most recent additions to the RaySearch product line are RayIntelligence® and RayCommand®*. RayIntelligence is an oncology analytics system (OAS) which enables cancer clinics to collect, structure and analyze data. RayCommand, a treatment control system (TCS), is designed to link the treatment machine and the treatment planning and oncology information systems.
RaySearch's software has been sold to over 900 clinics in more than 40 countries. The company was founded in 2000 as a spin-off from the Karolinska Institute in Stockholm and the share has been listed on Nasdaq Stockholm since 2003. More information is available at raysearchlabs.com.
About RayCare
The RayCare®* oncology information system (OIS) is designed to support the many complex logistical challenges faced by today’s oncology clinics. RayCare is closely integrated with RayStation®* and provides seamless access to all the powerful planning tools in RayStation and RayCommand®. The system efficiently coordinates activities in radiation therapy and offers advanced features for clinical workflow automation, and adaptive radiation therapy. RayCare responds to the demand from clinics for a more user-friendly and workflow-oriented information system that can support the cancer care of the future.
* Subject to regulatory clearance in some markets.
Tags:
